| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/25/2012 | CN102327278A Application of carborane derivatives, nano compound preparation and application of nano compound preparation |
| 01/25/2012 | CN102327276A Injecta for treating bacterial encephalitis of dog and preparation method thereof |
| 01/25/2012 | CN102327273A Compound clobetasol propionate nano-medicament and preparation method thereof |
| 01/25/2012 | CN102327270A Beta-lactam compound antibiotic composition |
| 01/25/2012 | CN102327269A Solid lipidosome preparation of compound cefaclor medicinal composition |
| 01/25/2012 | CN102327268A Oral liquid for treating coccidium and white diarrhea polyinfection and preparation method thereof |
| 01/25/2012 | CN102327261A Method for purifying coriamyrtin substance |
| 01/25/2012 | CN102327249A Lamivudine tablet composition and preparation method thereof |
| 01/25/2012 | CN102327242A Polyethylene glycol-integrated interferon variant lyophilized preparation |
| 01/25/2012 | CN102327241A Polyethylene glycol-integrated interferon variant freeze-dried preparation |
| 01/25/2012 | CN102327240A Cefbuperazone sodium medicinal composite for injection and preparation method thereof |
| 01/25/2012 | CN102327235A Solid cefixime lipid nanoparticle preparation |
| 01/25/2012 | CN102327228A Preparation method of chitosan newcastle disease vaccine nanoparticles |
| 01/25/2012 | CN102327227A Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid |
| 01/25/2012 | CN102327226A Solid cefprozi lipid nanoparticle preparation |
| 01/25/2012 | CN102327225A Tilmicosin liposome injection and preparation method thereof |
| 01/25/2012 | CN102327221A Cefadroxil liposome solid preparation |
| 01/25/2012 | CN102327218A Cefdinir liposome solid preparation |
| 01/25/2012 | CN102327217A Solid cefpodoxime proxetil liposome preparation |
| 01/25/2012 | CN102327215A Medecamycin nanoemulsion antibacterial drug and preparation method thereof |
| 01/25/2012 | CN102327201A Non-alcohol bioactive essential oil mouth rinses |
| 01/25/2012 | CN102327002A Health-care functional quilt core |
| 01/25/2012 | CN102180952B Foot and mouth disease virus antigen polypeptide, fusion antigen polypeptide and vaccine |
| 01/25/2012 | CN102091006B Tea extract facial cleanser and preparation method thereof |
| 01/25/2012 | CN102058764B Medicinal composition for treating acquired immune deficiency syndrome (AIDS) and application thereof |
| 01/25/2012 | CN102058584B Preparation method of potassium clavulanate/microcrystalline cellulose composition |
| 01/25/2012 | CN102018780B Skin bacteriostatic agent and preparation method thereof |
| 01/25/2012 | CN102000214B Traditional Chinese herbal medicament for treating herpes |
| 01/25/2012 | CN101953950B Chinese medicament for treating viral keratitis |
| 01/25/2012 | CN101947301B Medicine composition for preventing and treating vital myocarditis and preparation method thereof |
| 01/25/2012 | CN101904884B Quality detection method for Chinese medicinal compound isatis root granules |
| 01/25/2012 | CN101829063B Lung targeting microsphere of veterinary ceftiofur hydrochloride and preparation method |
| 01/25/2012 | CN101822842B Reformation of high-pathogenicity avian influenza virus H5N1-HA gene and recombinant adeno-associated virus vaccine thereof |
| 01/25/2012 | CN101822621B External solution for eliminating body odor |
| 01/25/2012 | CN101792437B Tolyltriazole derivatives, preparation method thereof and use thereof |
| 01/25/2012 | CN101780272B Application of autovaccine preparation containing TGF beta 1 |
| 01/25/2012 | CN101773520B Compound antimicrobial containing polyvalent silver ions and preparation method thereof |
| 01/25/2012 | CN101757090B Medicine composite for treating avian infectious bronchitis nephritis as well as preparation method and application thereof |
| 01/25/2012 | CN101721713B Cyclodextrin inclusion compound of 3,5-dyhydroxyl-4-isopropyl toluylene and preparation method thereof |
| 01/25/2012 | CN101703484B Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection |
| 01/25/2012 | CN101683519B Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof |
| 01/25/2012 | CN101664396B Azithromycin soft capsules and preparation method thereof |
| 01/25/2012 | CN101658668B Method and application for preparing bacteria simulacrum by using antibacterial peptide |
| 01/25/2012 | CN101647786B Aciclovir sustained-release tablet and preparation method thereof |
| 01/25/2012 | CN101633672B Novel nucleoside compound as well as preparation method and application thereof |
| 01/25/2012 | CN101606981B Method for extracting component with activities of microbiological resistance and anti-inflammatory from nelumbo nucifer (nulumbo lutea) plant |
| 01/25/2012 | CN101595874B Validamycin amphiphilic polymer network and synthesis method thereof |
| 01/25/2012 | CN101569656B Traditional Chinese medicine preparation and preparation method thereof |
| 01/25/2012 | CN101549046B Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma |
| 01/25/2012 | CN101549002B Tincture for curing flat wart and method for preparing the same |
| 01/25/2012 | CN101525610B Application of earthworm fibronectin enzyme in treating hepatitis B |
| 01/25/2012 | CN101474240B Method for extracting total flavone from mimosa |
| 01/25/2012 | CN101450209B Preparation method of transdermal immune influenza multivalent vaccine |
| 01/25/2012 | CN101429187B Ketone compound, preparation method and application thereof |
| 01/25/2012 | CN101406697B Preparation method of bacillus pyocyaneus vaccine |
| 01/25/2012 | CN101402687B Fusion protein with high immunogenicity and uses thereof |
| 01/25/2012 | CN101380467B Multi-connection inactivated vaccine (antigen) liquid concentration technique |
| 01/25/2012 | CN101341160B Process for production of water-soluble azole prodrug |
| 01/25/2012 | CN101293931B Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof |
| 01/25/2012 | CN101269067B Antibacterial gynecology externally used pharmaceutical combination |
| 01/25/2012 | CN101167811B External-applied preparation with anti-inflammation, itching-relieving and sterilization function and manufacturing method and application thereof |
| 01/25/2012 | CN101085355B 5-flucytosine/hydrotalcite-like nano hybrid compound and preparation method thereof |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101629 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101595 Antiviral indoles |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101575 Glycopeptide phosphonate derivatives |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101209 Absorption in upper part oof digestive system; oral administering |
| 01/24/2012 | US8101194 Immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/24/2012 | US8101176 Compositions and methods related to TIM-3, a TH1-specific cell surface molecule |
| 01/24/2012 | CA2671482C Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators |
| 01/24/2012 | CA2597812C Parenteral combination therapy for infective conditions with drug resistant bacterium |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2496698C 5-h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 01/24/2012 | CA2494340C Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections |
| 01/24/2012 | CA2493644C Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/24/2012 | CA2461647C Lysin-deficient bacteriophages having reduced immunogenicity |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2378802C Inactivated vaccine against feline calicivirus disease |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2269078C Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/20/2012 | CA2735631A1 Curcumin formulations and methods for making such formulations |
| 01/19/2012 | WO2012009707A2 Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| 01/19/2012 | WO2012009699A2 Process for preparing antiviral compounds |
| 01/19/2012 | WO2012009503A1 Palatable pharmaceutical composition comprising vx-950 |
| 01/19/2012 | WO2012009472A2 Structure, synthesis, and applications for oligo phenylene ethynylenes (opes) |
| 01/19/2012 | WO2012009446A1 Novel pyrimidinecarboxamide derivatives |
| 01/19/2012 | WO2012009134A1 Crth2 modulators |
| 01/19/2012 | WO2012008869A1 Aprotinin-based aerosol preparation for the treatment of viral respiratory infections |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012007711A1 Formulation comprising a type b lantibiotic |